LOL well to be precise I did not post that interview. BUT it s profoundly disappointing that only one side of that point is made, LL did indeed mistakenly claim that the FDA mandated the crossover, however the official SAP said::
per the demand of investigators and patients it was necessary to include a crossover option in the Protocol in order to recruit and retain patients.
I believe in airing all sides of the argument LOL LOL